PT1289999E - Analogos antitumorais de et-743 - Google Patents

Analogos antitumorais de et-743

Info

Publication number
PT1289999E
PT1289999E PT01929813T PT01929813T PT1289999E PT 1289999 E PT1289999 E PT 1289999E PT 01929813 T PT01929813 T PT 01929813T PT 01929813 T PT01929813 T PT 01929813T PT 1289999 E PT1289999 E PT 1289999E
Authority
PT
Portugal
Prior art keywords
hydroxy
spiroamine
protecting group
bridge
ecteinascidin
Prior art date
Application number
PT01929813T
Other languages
English (en)
Inventor
Carmen Pharma Mar S A Cuevas
Ignacio Pharma Mar Manzanares
Marta Pharma Mar S A Perez
Maria Jesus Pharma Mar Martin
Alberto Pharma Mar S Rodriguez
Simon Pharma Mar S A Munt
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2000/001852 external-priority patent/WO2000069862A2/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of PT1289999E publication Critical patent/PT1289999E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Discharging, Photosensitive Material Shape In Electrophotography (AREA)
  • Pyrane Compounds (AREA)
  • Instruments For Viewing The Inside Of Hollow Bodies (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
PT01929813T 2000-05-15 2001-05-15 Analogos antitumorais de et-743 PT1289999E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/GB2000/001852 WO2000069862A2 (en) 1999-05-14 2000-05-15 Hemisynthetic method and intermediates thereof
PCT/GB2001/002110 WO2001087894A1 (en) 1999-05-14 2001-05-15 Antitumoral analogs of et-743

Publications (1)

Publication Number Publication Date
PT1289999E true PT1289999E (pt) 2005-03-31

Family

ID=34855248

Family Applications (3)

Application Number Title Priority Date Filing Date
PT04010399T PT1496060E (pt) 2000-05-15 2001-05-15 Análogos antitumurais de et-743
PT01929816T PT1287004E (pt) 2000-05-15 2001-05-15 Processo sintetico para a producao de um composto ecteinascidina
PT01929813T PT1289999E (pt) 2000-05-15 2001-05-15 Analogos antitumorais de et-743

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT04010399T PT1496060E (pt) 2000-05-15 2001-05-15 Análogos antitumurais de et-743
PT01929816T PT1287004E (pt) 2000-05-15 2001-05-15 Processo sintetico para a producao de um composto ecteinascidina

Country Status (17)

Country Link
EP (3) EP1287004B1 (pt)
KR (2) KR100830717B1 (pt)
AT (2) ATE300547T1 (pt)
AU (2) AU783563B2 (pt)
DE (3) DE60129753T2 (pt)
DK (3) DK1289999T3 (pt)
EA (2) EA006369B1 (pt)
ES (2) ES2290583T3 (pt)
GB (1) GB9918178D0 (pt)
HK (1) HK1050193A1 (pt)
HU (1) HU228789B1 (pt)
MX (1) MXPA02010701A (pt)
NZ (2) NZ532793A (pt)
PL (2) PL215769B1 (pt)
PT (3) PT1496060E (pt)
SI (2) SI1496060T1 (pt)
UA (1) UA75597C2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1658848T3 (pl) 2004-10-29 2007-12-31 Pharma Mar Sa Preparaty zawierające ekteinascydynę i disacharyd
KR100676325B1 (ko) * 2005-03-15 2007-01-30 삼성전자주식회사 디스플레이장치
KR100676324B1 (ko) * 2005-03-15 2007-01-30 삼성전자주식회사 디스플레이장치
KR100712667B1 (ko) * 2006-04-11 2007-05-02 재단법인서울대학교산학협력재단 신규한 디아자 헤테로고리 유도체 및 그의 고체상 제조방법
JP6037337B2 (ja) * 2010-05-25 2016-12-07 ファルマ、マール、ソシエダード、アノニマＰｈａｒｍａ Ｍｒｓ，Ｓ．Ａ． エクチナサイジン化合物の製造のための合成方法
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
WO2020105068A1 (en) * 2018-11-24 2020-05-28 Natco Pharma Limited Process for the preparation of ecteinascidin derivative and its intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59225189A (ja) 1983-06-03 1984-12-18 Shionogi & Co Ltd キノナミン誘導体およびその製造法
ATE69234T1 (de) * 1986-06-09 1991-11-15 Univ Illinois Ekteinascidine 729, 743, 745, 759a, 759b and 770.
US5721362A (en) * 1996-09-18 1998-02-24 President And Fellows Of Harvard College Process for producing ecteinascidin compounds
US6124292A (en) * 1998-09-30 2000-09-26 President And Fellows Of Harvard College Synthetic analogs of ecteinascidin-743

Also Published As

Publication number Publication date
PL358143A1 (en) 2004-08-09
AU783563B2 (en) 2005-11-10
ES2248319T3 (es) 2006-03-16
ATE300547T1 (de) 2005-08-15
HUP0300648A2 (hu) 2003-07-28
UA75597C2 (en) 2006-05-15
ATE368671T1 (de) 2007-08-15
EP1287004A1 (en) 2003-03-05
EA200201209A1 (ru) 2003-04-24
EA006369B1 (ru) 2005-12-29
EP1289999A1 (en) 2003-03-12
EP1496060B1 (en) 2007-08-01
EP1289999B1 (en) 2004-11-17
KR100830717B1 (ko) 2008-05-20
DE60107241D1 (de) 2004-12-23
PT1287004E (pt) 2005-11-30
KR20030005308A (ko) 2003-01-17
DK1289999T3 (da) 2005-03-14
EP1496060A1 (en) 2005-01-12
KR20030031481A (ko) 2003-04-21
DE60129753D1 (de) 2007-09-13
EP1287004B1 (en) 2005-07-27
DE60112286D1 (de) 2005-09-01
AU2001256496C1 (en) 2006-08-03
AU5649301A (en) 2001-11-26
NZ521807A (en) 2004-06-25
HK1050193A1 (en) 2003-06-13
EA200201210A1 (ru) 2003-04-24
KR100777464B1 (ko) 2007-11-27
PL358258A1 (en) 2004-08-09
DE60112286T2 (de) 2006-06-01
HUP0300648A3 (en) 2006-05-29
NZ532793A (en) 2004-10-29
EA006070B1 (ru) 2005-08-25
AU2001256496B2 (en) 2006-02-16
DK1287004T3 (da) 2005-11-28
PT1496060E (pt) 2007-10-30
SI1289999T1 (en) 2005-06-30
PL203745B1 (pl) 2009-11-30
DK1496060T3 (da) 2007-12-03
DE60107241T2 (de) 2006-08-03
HU228789B1 (en) 2013-05-28
GB9918178D0 (en) 1999-10-06
PL215769B1 (pl) 2014-01-31
ES2290583T3 (es) 2008-02-16
SI1496060T1 (sl) 2008-06-30
MXPA02010701A (es) 2003-05-14
DE60129753T2 (de) 2008-04-30

Similar Documents

Publication Publication Date Title
BR9916027A (pt) Análogos de glp-1
BR9915961A (pt) Análogos de glp-1
EP1411052A4 (en) BENZO-CONDENSED 5-CHAIN HETEROCYCLE COMPOUNDS, PROCESS FOR PREPARING SAME AND USE THEREOF
BRPI0407507A (pt) derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona, processos para sua preparação de sua aplicação como medicamento
BRPI0407387A (pt) Derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona substituìdos por nitrogênio, processos para a sua preparação e sua aplicação com medicamento
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
PT1289999E (pt) Analogos antitumorais de et-743
ZM987A1 (en) New dihydrobenzofuran and chroman-carboxamide derivatives,processes for the preparation thereof and use thereof as neuroleptics
BR9507231A (pt) Uso de derivados de ácido carboxílico para a produção de drogas
DE69434652D1 (de) Antikonvulsive pseudofructopyranose sulfamate
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
BR0017175A (pt) Modificação da torasemida amorfa
BR9611572A (pt) Produção de um sal de ácido clavulânico
SE0004462D0 (sv) Novel method and use
NO953573D0 (no) Benzopyraner som kaliumkanalåpnere
SE9704834D0 (sv) New process
DE69411380T2 (de) Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung